Namal Liyanage

Assistant Professor

The Ohio State University Wexner Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Slim Fourati

Assistant Professor

Northwestern University Feinberg School of Medicine

UNITED STATES

View details

Emrah Gecili

Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

Eunsoo Kim

Assistant Professor

Pusan National University

SOUTH KOREA

View details

Assem Ziady

Tenured Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Namal Liyanage

Research Interests

Explore related searches

Contact this professor

Articles (8)

Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c.

Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection

Inhibition of elastase enhances the adjuvanticity of alum and promotes anti–SARS-CoV-2 systemic and mucosal immunity

Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates.

Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.

Erratum to: Attenuation of Helper T Cell Capacity for TH1 and TH17 Differentiation in Children With Nontuberculous Mycobacterial Infection.

Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.

Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition.

Collaborators (4)

Slim Fourati

Emrah Gecili

Eunsoo Kim

Assem Ziady

Make your next move.